FUTURE OUTLOOK
India's plans for promoting its biopharmaceutical and other biotech sectors are fairly ambitious and may be more difficult
to realize as swiftly as the country's planners would like. As with many government initiatives around the globe, the DBT's
budget (approaching $200 million in 2008) would seem to be spread thinly if it is to accommodate the long list of priority
projects the organization intends to support.9
Still, India clearly is intent on improving itself in the biotech sector, and the desire to make Indian biotech as good as
Indian IT seems to be widespread. It is, therefore, likely that in another decade, India will at least have one of Asia's
best biotech capabilities.
REFRENCES
1. Biocon looks to Rs 650-cr SEZ for tax relief. The Hindu Business Line. 2005 Oct 20. Available from:
http://www.thehindubusiness-line.com/2005/10/20/stories/2005102001630200.htm
2. The Patents Amendment Act, 2005. Available from:
http://www.patentoffice.nic.in/ipr/patent/patent_2005.pdf
3. Yarnell A. Keeping postdocs at home in India. Chem Eng News 84. 2006 Mar 20. Available from:
http://www.pubs.acs.org/cen/coverstory/84/8412India3.html
4. Department of Biotechnology. National Biotechnology Development Strategy. 2007 Nov. Available from:
http://www.dbtindia.nic.in/biotechstrategy/National%20Biotechnology%20Development%20Strategy.pdf
5. Department of Plant and Molecular Biology, University of Delhi. India's national biotechnology regulatory authority functional
in two years. Available from:
http://www.south.du.ac.in/pmb/mod.php?mod=publisher&op=viewarticle&artid=55
6. Kumar A. Biogeneric manufacturing in India. In: Langer E, editor. Advances in biopharmaceutical technology in India. Gaithersburgh,
MD: Bioplan; 2008 Feb.
7. Singh S. India doles out pharma incentives. Red Herring. 2007 Feb 27. Available from:
http://www.redherring.com/Home/21468
8. India Brand Equity Foundation/Ernst & Young. Biotechnology. Available from:
http://www.tamilnadunri.com/Indian%20Market/26.%20Bio-technology.pdf
9. Clearstate Pte. Ltd. Biotech: India's new global pitch. 2007 Jul 23. Available from:
http://www.clearstate.com/admin/data/Clearstate_India_Biotech.pdf
Eric S. Langer is president and managing partner at BioPlan Associates, Inc., Rockville, MD. He is also the editor of Advances in Biopharmaceutical Technology in India, 301.921.9074, elanger@bioplanassociates.com
|
